232 related articles for article (PubMed ID: 4091990)
1. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
Mucklow JC; Kuhn S
Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of four slow-release theophylline formulations in the beagle dog.
Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
4. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
Stein GE; Haughey DB; Ross RJ; Vakoutis J
Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
[TBL] [Abstract][Full Text] [Related]
5. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
Hurwitz A; Karim A; Burns TS
J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
[TBL] [Abstract][Full Text] [Related]
6. Absorption of sustained-release theophylline tablets.
Fagerström PO; Heintz L
Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
[TBL] [Abstract][Full Text] [Related]
7. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
[TBL] [Abstract][Full Text] [Related]
8. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
Dockhorn RJ; Cefali EA; Straughn AB
Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
10. The influence of antacid on the absorption of two different sustained-release formulations of theophylline.
Myhre KI; Walstad RA
Br J Clin Pharmacol; 1983 Jun; 15(6):683-7. PubMed ID: 6871067
[TBL] [Abstract][Full Text] [Related]
11. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
[TBL] [Abstract][Full Text] [Related]
12. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
Bialer M; Salame K; Raz I
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
[TBL] [Abstract][Full Text] [Related]
13. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
Clarke DF; Werbowsky OL; Grodin MA; Shargel L
Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
[TBL] [Abstract][Full Text] [Related]
14. Methods of comparing pharmacokinetics of slow release preparations: a comparison of "Theo-Dur" and "Phyllocontin" in patients with asthma.
Jackson SH; Shah K; Turner P
Eur J Clin Pharmacol; 1986; 30(3):313-7. PubMed ID: 3732367
[TBL] [Abstract][Full Text] [Related]
15. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
16. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
17. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
18. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
Rogers RJ; Wiener MB; Hill MR; Szefler SJ
Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
[TBL] [Abstract][Full Text] [Related]
19. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.
Osman MA; Patel RB; Irwin DS; Welling PG
Biopharm Drug Dispos; 1983; 4(1):63-72. PubMed ID: 6839003
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release theophylline pharmacokinetics in the cat.
Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
